8UUN
Prototypic SARS-CoV-2 spike (containing V417) in the closed conformation
8UUN の概要
エントリーDOI | 10.2210/pdb8uun/pdb |
EMDBエントリー | 42589 42590 42591 42592 |
分子名称 | Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total) |
機能のキーワード | prototypic sars-cov-2 spike v417, viral protein |
由来する生物種 | Severe acute respiratory syndrome coronavirus 2 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 408657.16 |
構造登録者 | |
主引用文献 | Geng, Q.,Wan, Y.,Hsueh, F.C.,Shang, J.,Ye, G.,Bu, F.,Herbst, M.,Wilkens, R.,Liu, B.,Li, F. Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein. Elife, 12:-, 2023 Cited by PubMed Abstract: SARS-CoV-2 spike protein plays a key role in mediating viral entry and inducing host immune responses. It can adopt either an open or closed conformation based on the position of its receptor-binding domain (RBD). It is yet unclear what causes these conformational changes or how they influence the spike's functions. Here, we show that Lys417 in the RBD plays dual roles in the spike's structure: it stabilizes the closed conformation of the trimeric spike by mediating inter-spike-subunit interactions; it also directly interacts with ACE2 receptor. Hence, a K417V mutation has opposing effects on the spike's function: it opens up the spike for better ACE2 binding while weakening the RBD's direct binding to ACE2. The net outcomes of this mutation are to allow the spike to bind ACE2 with higher probability and mediate viral entry more efficiently, but become more exposed to neutralizing antibodies. Given that residue 417 has been a viral mutational hotspot, SARS-CoV-2 may have been evolving to strike a balance between infection potency and immune evasion, contributing to its pandemic spread. PubMed: 37991488DOI: 10.7554/eLife.74060 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (3.8 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード